The total return over the past 12 months is +46.07% vs. +16.94% for the S&P 500. So far it's up +6.68% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +46.07% | +7.38% | +0.91% | N/A | N/A | N/A |
| Total Return CAGR | +46.07% | +7.38% | +0.91% | N/A | N/A | N/A |
| Revenue CAGR | +24.25% | +24.37% | +32.47% | N/A | N/A | N/A |
| Net Income CAGR | +0.20% | +6.94% | +50.86% | N/A | N/A | N/A |
| EPS CAGR | (1.26%) | +12.77% | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | +37.17% | +30.08% | +48.43% | N/A | N/A | N/A |
| Operating Cash Flow CAGR | +36.90% | +30.02% | +48.32% | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Harmony Biosciences Holdings, Inc. (HRMY)
| Year | Start price | End price | HRMY Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $37.42 | $39.92 | +6.68% | +14.51% | (7.83%) |
| 2025 | $34.41 | $37.42 | +8.75% | +17.72% | (8.97%) |
| 2024 | $32.30 | $34.41 | +6.53% | +24.89% | (18.36%) |
| 2023 | $55.10 | $32.30 | (41.38%) | +26.19% | (67.57%) |
| 2022 | $42.64 | $55.10 | +29.22% | (18.17%) | +47.39% |
| 2021 | $36.15 | $42.64 | +17.95% | +28.74% | (10.79%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
